ClinicalTrials.Veeva

Menu

Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo

B

Butantan Institute

Status

Completed

Conditions

SARS-CoV 2
COVID

Treatments

Diagnostic Test: Serological test
Diagnostic Test: Oropharyngeal Swab
Diagnostic Test: Nasopharyngeal Swab

Study type

Observational

Funder types

Other

Identifiers

NCT04408014
COVID-19-Epi-01

Details and patient eligibility

About

Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo

Full description

This is a cross-sectional study to estimate the prevalence of antibodies against SARS-CoV-2 is different population subgroups in the State of São Paulo

Enrollment

18,901 patients

Sex

All

Ages

6 months to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All potential volunteers invited to participate in the study.

Exclusion criteria

  • All potential eligible participants, but who do not show interest in participating in the study.

Trial design

18,901 participants in 8 patient groups

HC-USP
Description:
Home contacts of health professionals diagnosed with COVID-19 at the Hospital of Clínic of Medicine School of the University of São Paulo
Treatment:
Diagnostic Test: Nasopharyngeal Swab
Diagnostic Test: Oropharyngeal Swab
Diagnostic Test: Serological test
CORAS
Description:
Refugees living in the city of São Paulo
Treatment:
Diagnostic Test: Nasopharyngeal Swab
Diagnostic Test: Oropharyngeal Swab
Diagnostic Test: Serological test
Hemocenter
Description:
Blood Donors of the Pró-Sangue Hemocenter Foundation of São Paulo
Treatment:
Diagnostic Test: Serological test
CPP - Butantan Penitentiary Progression Center
Description:
Participants of the CPP - Butantan Penitentiary Progression Center
Treatment:
Diagnostic Test: Nasopharyngeal Swab
Diagnostic Test: Oropharyngeal Swab
Diagnostic Test: Serological test
CHSP - Penitentiary System Hospital Center
Description:
Participants of the CHSP - Penitentiary System Hospital Center
Treatment:
Diagnostic Test: Nasopharyngeal Swab
Diagnostic Test: Oropharyngeal Swab
Diagnostic Test: Serological test
SABE (Health, Wellness and Aging)
Description:
Participants of the SABE Project (Health, Wellness and Aging)
Treatment:
Diagnostic Test: Nasopharyngeal Swab
Diagnostic Test: Oropharyngeal Swab
Diagnostic Test: Serological test
ILPI - Long-Term Care Institution for the Elderly
Description:
Residents of the Long-Term Care Institution for the Elderly of Botucatu
Treatment:
Diagnostic Test: Nasopharyngeal Swab
Diagnostic Test: Oropharyngeal Swab
Diagnostic Test: Serological test
ICR-USP - Children's Institute of HCFMUSP
Description:
Home contacts of children and adolescents diagnosed with COVID-19, attended at the Children's Institute of HCFMUSP
Treatment:
Diagnostic Test: Nasopharyngeal Swab
Diagnostic Test: Oropharyngeal Swab
Diagnostic Test: Serological test

Trial contacts and locations

1

Loading...

Central trial contact

Alexander R Precioso, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems